CMKLR2-AS: A Potential Drug Target and Biomarker (G101669764)

Target Name: CMKLR2-AS

NCBI ID: G101669764

CMKLR2-AS

Other Name(s): GPR1-AS1 | GPR1-AS | CMKLR2 antisense RNA | GPR1AS

CMKLR2-AS: A Potential Drug Target and Biomarker

CMKLR2-AS is a protein that is expressed in various tissues, including the brain, and is known for its role in the regulation of cell survival and proliferation. The identification of potential drug targets and biomarkers is a critical step in the development of new treatments for various diseases. In this article, we will discuss the potential implications of CMKLR2-AS as a drug target and biomarker.

Potential Drug Target

CMKLR2-AS has been identified as a potential drug target due to its involvement in various cellular processes that are crucial for cancer growth and progression. One of the key functions of CMKLR2-AS is its role in the regulation of apoptosis, which is a natural process that helps eliminate damaged or dysfunctional cells.

Studies have shown that CMKLR2-AS is involved in the regulation of apoptosis in various tissues, including the brain. In fact, researchers have found that CMKLR2-AS is highly expressed in the brain and that its levels are correlated with the expression of genes that are involved in cell death.

In addition, CMKLR2-AS has been shown to play a role in the regulation of cell survival and proliferation. Studies have shown that CMKLR2-AS can inhibit the activity of various signaling pathways that promote cell growth and proliferation, including the PI3K/Akt signaling pathway.

Potential Biomarker

CMKLR2-AS has also been identified as a potential biomarker for various diseases, including cancer. The regulation of apoptosis is a critical process that is disrupted in many types of cancer, including neurocancer.

Studies have shown that CMKLR2-AS is often expressed in various types of cancer, including neurocancer. In addition, researchers have found that CMKLR2-AS is involved in the regulation of apoptosis in various types of cancer, including neurocancer.

Conclusion

In conclusion, CMKLR2-AS is a protein that has been identified as a potential drug target and biomarker. The regulation of apoptosis is a critical process that is involved in the regulation of cell survival and proliferation, and the identification of potential drug targets and biomarkers is a critical step in the development of new treatments for various diseases. Further research is needed to determine the full implications of CMKLR2-AS as a potential drug target and biomarker.

Protein Name: CMKLR2 Antisense RNA

The "CMKLR2-AS Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CMKLR2-AS comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets